Gadeta Overview

  • Founded
  • 2015
  • Status
  • Private
  • Employees
  • 37
  • Latest Deal Type
  • Corporate
  • Investors
  • 4

Gadeta General Information


Developer of innovative immunotherapies designed to treat cancer effectively. The company's innovative immunotherapies are based on the discoveries regarding the role of yo T cell receptors (TCR's) in the broad recognition of hematological and solid tumor cells and their potential use for the treatment of advanced malignancies, enabling healthcare institutions and cancer patients to eradicate both hematological and solid tumors lowering the chances of cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Yalelaan 62
  • 3584 CM Utrecht
  • Netherlands
+31 085 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Gadeta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Corporate 19-Jul-2018 00.000 Completed Generating Revenue
2. Early Stage VC (Series A) 29-Mar-2016 00.000 00.000 Completed Startup
1. Seed Round Completed Startup
To view Gadeta’s complete valuation and funding history, request access »

Gadeta Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of innovative immunotherapies designed to treat cancer effectively. The company's innovative immunotherapies a
Utrecht, Netherlands
37 As of 2020
000000000000 00.000


dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui
0000 000000000
Philadelphia, PA
00 As of 0000
00000000000 00000


nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor
Gaithersburg, MD
00 As of 0000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Gadeta Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Carisma Therapeutics Venture Capital-Backed Philadelphia, PA 00 00000 00000000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000 000000000000 Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
0000000 Formerly VC-backed Tübingen, Germany 000 00.000 00000000 00.000
You’re viewing 5 of 21 competitors. Get the full list »

Gadeta Executive Team (7)

Name Title Board Seat Contact Info
Nathalie Laarakker-James Chief Financial Officer
Jurgen Kuball MD Scientific Co-Founder
Marco Londei MD Chief Executive Officer
Tolleiv Trimborn Ph.D Chief Operating Officer
You’re viewing 4 of 7 executive team members. Get the full list »

Gadeta Board Members (6)

Name Representing Role Since
Giovanni Mariggi Ph.D Medicxi Board Member 000 0000
Michèle Ollier MD Medicxi Board Member 000 0000
Oscar Schoots Ph.D Utrecht Holdings Board Member 000 0000
Peter Emtage Gadeta Board Member 000 0000
You’re viewing 4 of 6 board members. Get the full list »

Gadeta Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gadeta Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kite Pharma Corporation Majority 000 0000 000000 0
Baxalta Ventures Corporate Venture Capital Minority 000 0000 000000 0
Medicxi Venture Capital Minority 000 0000 000000 0
Utrecht Holdings Venture Capital Minority 000 0000 000000 0
To view Gadeta’s complete investors history, request access »